COMMUNIQUÉS West-GlobeNewswire

SOGC Statement on CMA Apology to Indigenous Peoples

18/09/2024 - 22:30

VICTORIA, British Columbia, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Today, the Society of Obstetricians and Gynaecologists of Canada (SOGC) stands in solidarity with the Canadian Medical Association (CMA) in its apology for [...]

Déclaration de la SOGC sur les excuses de l'AMC pour les torts causés aux peuples autochtones

18/09/2024 - 22:30

VICTORIA, C.-B., 18 sept. 2024 (GLOBE NEWSWIRE) -- Aujourd'hui, la Société des obstétriciens et gynécologues du Canada (SOGC) est solidaire avec l'Association médicale canadienne (AMC) dans ses excuses pour les torts [...]

NANOBIOTIX Provides Business Update and Reports Half Year 2024 Financial Results

18/09/2024 - 22:15

RT-NBTXR3 followed by anti-PD-1 demonstrated favorable safety profile, disease control and tumor response in patients both naïve and resistant to anti-PD-1, suggesting that NBTXR3 may prime the immune system before [...]

NANOBIOTIX fait le point sur ses activités et publie ses résultats financiers pour le premier semestre 2024

18/09/2024 - 22:15

NBTXR3 activé par radiothérapie suivi d’un anti-PD-1 a montré un profil de sécurité favorable, un contrôle de la maladie et une réponse tumorale chez les patients naïfs et résistants aux anti-PD-1, suggérant que NBTXR3 [...]

SciSparc Takes Major Step Forward with IND Application submitted to the FDA for Phase IIb Clinical Trial for Tourette Syndrome Treatment

18/09/2024 - 22:09

Yale Child Study Center at the Yale School of Medicine in the USA, Hannover Medical School in Germany and Tel Aviv Sourasky Medical Center in Israel will take part in the trial TEL AVIV, Israel, Sept. 18, 2024 (GLOBE [...]

Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with Bayer

18/09/2024 - 22:05

DUBLIN, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, [...]

Enliven Therapeutics Announces Details Regarding the Presentation of Updated ELVN-001 Phase 1a Data at the ESH-iCMLf 26th Annual John Goldman Conference on CML

18/09/2024 - 22:05

BOULDER, Colo., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage precision oncology company focused on the discovery and development of next- [...]

QIAGEN expands QIAcuity digital PCR offering with over new 100 assays via GeneGlobe platform

18/09/2024 - 22:05

QIAGEN adds over 100 new validated QIAcuity digital PCR assays for cancer research, inherited genetic disorders, infectious disease surveillance, and other applications // QIAcuity digital PCR enables accurate and [...]

4DMT Highlights Robust and Durable Clinical Activity for 4D-150 and Design of 4FRONT Phase 3 Program at 4D-150 Wet AMD Development Day

18/09/2024 - 22:05

4D-150 demonstrated robust and durable clinical activity across all wet age-related macular degeneration (wet AMD) patient populations based on longest available follow-up data In broad population (Phase 2b), 70% [...]

Ascendis Pharma A/S Announces Proposed Public Offering of ADSs

18/09/2024 - 22:04

COPENHAGEN, Denmark, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that it has commenced an underwritten public offering of $300,000,000 of American Depositary Shares (“ADSs”), [...]

NTG Nordic Transport Group acquires ITC Logistics

18/09/2024 - 20:05

Company announcement no. 8 – 24 18 September 2024 NTG Nordic Transport Group acquires ITC Logistics NTG Germany GmbH (“NTG”), a fully owned subsidiary of NTG Nordic Transport Group A/S, has signed an agreement to [...]

Thought Leadership & Innovation Foundation Proudly Accepts Ownership of Limb Loss and Preservation Registry in Collaboration with Amputee Coalition

18/09/2024 - 19:38

McLEAN, Va., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Thought Leadership & Innovation Foundation (TLI) , a not-for-profit organization that works at the nexus of science, technology and public health, today announces the [...]

SoCalBio’s 26th Annual Two-Day Investor Partnership Conference hosted at the Hyatt Regency Newport Beach for the Medical Device and Biotechnology Industry

18/09/2024 - 19:14

Annual Conference in Orange County Will Showcase Latest Bioscience Advancements in AI, Diagnostics, Therapeutics, Digital Health, Implantable and Wearable Medical Devices LOS ANGELES, Sept. 18, 2024 (GLOBE NEWSWIRE) -- [...]

Plant Advanced Technologies PAT : Bilan 1er semestre 2024 du contrat de liquidité

18/09/2024 - 18:00

Vandœuvre-lès-Nancy, le 18 septembre 2024 à 18h00 (CET) Communiqué de presse Pour diffusion immédiate BILAN PREMIER SEMESTRE 2024 DU CONTRAT DE LIQUIDITE Au titre du contrat de liquidité portant sur les actions de la [...]

Starton Therapeutics Announces Successful Feasibility Demonstration of STAR-LLD Using BD Evolve™ On-Body Injector

18/09/2024 - 16:46

Successful feasibility study underscores compatibility of STAR-LLD using On-body Injector (OBI) technology and Starton’s proprietary low-dose formulation of lenalidomide (LLD) Based on the positive feasibility study [...]

Tilray Medical lance la marque de cannabis Redecan en Australie

18/09/2024 - 16:11

Le cannabis Redecan, certifié BPF-UE, est désormais disponible sur prescription médicale en Australie NEW YORK, 18 sept. 2024 (GLOBE NEWSWIRE) -- Tilray Medical, une division de Tilray Brands, Inc. ("Tilray Brands") ( [...]

Corza Medical figure dans la liste MedTech Big 100 de 2024

18/09/2024 - 16:06

WESTWOOD, Massachusetts, 18 sept. 2024 (GLOBE NEWSWIRE) -- Corza Medical (“Corza” ou l'“Entreprise”), une entreprise de technologie médicale de premier rang à l'échelle mondiale, dédiée à proposer des services [...]

Kaida BioPharma Launches Social Media Channels

18/09/2024 - 16:00

Company dedicated to providing a new hope for patients with treatment-resistant gynecological cancers Lead program, KAD101 for the treatment of ovarian cancer rapidly advancing towards Phase 1 study, targeted for 2025 [...]

First cases using Smith+Nephew’s new CATALYSTEM™ Primary Hip System completed; surgeons hail precision, efficiency and reproducibility

18/09/2024 - 16:00

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces promising surgeon feedback from the first completed cases utilizing its new CATALYSTEM Primary Hip System. Designed to address the [...]